This compansy' shares have crashed 77 percent YTD. Consolidation may offer a new entry opportunity for this restructuring drug company. It is highly unlikely to go bankrupt. The drug company reaffirmed its revenue guidance as part of its 2nd quarter earnings release, and guided for significant debt reductions on the back of asset sales and free cash flow. Further, its new Chief Executive Officer put $8 billion of non core asset sales on the table in order to pay down the drug company's debt.
Drug company Valeant Pharmaceuticals International, Inc. (NYSE:VRX) was the most exciting story in the stock market of 2015/6 if you ask me. Unfortunately, shareholders of Valeant Pharmaceuticals that bought into the acquisition model a year ago are now sitting on devastating losses. I can only say congrats to all those investors that jumped off the sinking ship in time last year, and those investors that actually shorted the drug company.
Source: Seeking Alpha
Related Articles:
- 7 Undervalued, Big-Name Stocks To Consider For Your Dividend Portfolio
- 7 High-Yield Energy Stocks Growing Their Dividends
- 5 Dividend Stocks In Need Of A Market Correction
- 10 Dividend Stocks Building A Growing Cash Stream
- How To Build A Sustainable High Yield Portfolio
________________________________________________________________
Subscribe to:
Post Comments (Atom)
Popular Posts Last 30 Days
-
Late last year, Wall Street had a bit of a panic attack when Fed chairman Jerome Powell suggested this tightening was on autopilot. While th...
-
If you’ve been following this column, you’d know that monthly dividend stocks tend to come from two main types of businesses: real estate an...
-
Are you sick and tired of low interest rates? Certificates of deposit pay next to nothing. Bonds yield only three or four percent a year. Su...
-
These three picks are all up more than 10% so far in 2019. The three themes are LNG, specialized healthcare, and small banks. The yields ran...
-
This company makes a compelling value proposition based on valuation, risk/reward, yield, and upside potential. I added this hotel REIT las...
-
This company makes a compelling value proposition on the dip for DGI investors. The REIT has strong portfolio stats and a conservative AFFO-...
-
Showing resilience during a tough week was a group of stocks that has not been heard from much in the past two years. A group that has been ...
-
Stocks with high dividend yields can be great, but if a stock has a high dividend yield and also has lots of long-term growth potential and ...
-
If a company pays, say, 14%, you would only need to put up $71,429 to earn $10,000 in annual dividends. Of course, we know that double-digit...
-
There are a lot of reasons to consider adding high-dividend stocks to your portfolio. They offer a steady income that can help ease the pain...
0 comments
Post a Comment
Post a Comment